Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jan;24(1):59-67.
doi: 10.1111/codi.15934. Epub 2021 Nov 16.

Metabolic positron emission tomography/CT response after induction chemotherapy and chemo(re)irradiation is associated with higher negative resection margin rate in patients with locally recurrent rectal cancer

Desley M G I van Zoggel  1 , Eva L K Voogt  1 , Ineke G van Lijnschoten  2 , Jeltsje S Cnossen  3 , Geert-Jan Creemers  4 , Joost Nederend  5 , Johanne G Bloemen  1 , Grard A P Nieuwenhuijzen  1 , Pim J W A Burger  1 , Sabine G G F Lardenoije  6 , Harm J T Rutten  1   7 , Mark J Roef  6
Affiliations

Metabolic positron emission tomography/CT response after induction chemotherapy and chemo(re)irradiation is associated with higher negative resection margin rate in patients with locally recurrent rectal cancer

Desley M G I van Zoggel et al. Colorectal Dis. 2022 Jan.

Abstract

Aim: Positron emission tomography (PET)/CT can be used to monitor the metabolic changes that occur after intensified treatment with induction chemotherapy and chemo(re)irradiation for locally recurrent rectal cancer (LRRC). This study aimed to analyse the correlation between the PET/CT response and final histopathological outcomes.

Methods: All LRRC patients who underwent induction chemotherapy prior to surgery between January 2010 and July 2020 and were monitored with pretreatment and post-treatment PET/CT were included. Visual qualitative analysis was performed, and patients were scored as having achieved a complete metabolic response (CMR), partial metabolic response (PMR) or no response (NR). The histopathological response was assessed according to the Mandard tumour regression (TRG) score and categorized as major (TRG 1-2), partial (TRG 3) or poor (TRG 4-5). The PET/CT and TRG categories were compared, and possible confounders were analysed.

Results: A total of 106 patients were eligible for analysis; 24 (23%) had a CMR, 54 (51%) had a PMR and 28 (26%) had NR. PET/CT response was a significant predictor of the negative resection margin rate, achieving 96% for CMR, 69% for PMR and 50% for NR. The overall accuracy between PET score and pathological TRG was 45%, and the positive predictive value for CMR was 63%. A longer interval between post-treatment PET/CT and surgery negatively influenced the predictive value.

Conclusion: Metabolic PET/CT response evaluation after neoadjuvant treatment proves to be a complementary diagnostic tool to standard MRI in assessing tumour response, and may play a role for treatment planning in LRRC patients.

Keywords: FDG-PET/CT; histopathological response; induction chemotherapy; locally recurrent rectal cancer.

PubMed Disclaimer

References

REFERENCES

    1. van Zoggel DMGI, Bosman SJ, Kusters M, Nieuwenhuijzen GAP, Cnossen JS, Creemers GJ, et al. Preliminary results of a cohort study of induction chemotherapy-based treatment for locally recurrent rectal cancer. Br J Surg. 2018;105:447-52. https://doi.org/10.1002/bjs.10694
    1. Voogt ELK, van Zoggel DMGI, Kusters M, Nieuwenhuijzen GAP, Bloemen JG, Peulen HMU, et al. Improved outcomes for responders after treatment with induction chemotherapy and chemo(re)irradiation for locally recurrent rectal cancer. Ann Surg Oncol. 2020;27(9):3503-13. https://doi.org/10.1245/s10434-020-08362-4
    1. Peacock O, Chang GJ. ‘Watch and wait’ for complete clinical response after neoadjuvant chemoradiotherapy for rectal cancer. Minerva Chir. 2019;74:481-95.
    1. Dossa F, Chesney TR, Acuna SA, Baxter NN. A watch-and-wait approach for locally advanced rectal cancer after a clinical complete response following neoadjuvant chemoradiation: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2017;2:501-13. https://doi.org/10.1016/S2468-1253(17)30074-2
    1. Kusters M, Bosman SJ, Van Zoggel DMGI, Nieuwenhuijzen GAP, Creemers G-J, Van den Berg HA, et al. Local recurrence in the lateral lymph node compartment: improved outcomes with induction chemotherapy combined with multimodality treatment. Ann Surg Oncol. 2016;23:1883-9. https://doi.org/10.1245/S10434-016-5098-2

MeSH terms

Substances

LinkOut - more resources